Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

AKLI, SAID

One or more keywords matched the following items that are connected to AKLI, SAID

Item Type	Name
Academic Article	E1A can provoke G1 exit that is refractory to p21 and independent of activating cdk2.
Concept	Cyclin-Dependent Kinase 6
Concept	Cyclin-Dependent Kinases
Concept	Cyclin-Dependent Kinase Inhibitor p21
Concept	Cyclin E
Concept	Cyclin-Dependent Kinase 2
Concept	Cyclin-Dependent Kinase 4
Concept	Cyclin-Dependent Kinase Inhibitor p27
Concept	Cyclin-Dependent Kinase Inhibitor p16
Academic Article	Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cells.
Academic Article	LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patients.
Academic Article	Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy.
Academic Article	Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer.
Academic Article	Low-molecular-weight cyclin E: the missing link between biology and clinical outcome.
Academic Article	Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
Academic Article	A novel interaction between HER2/neu and cyclin E in breast cancer.
Academic Article	Deregulation of cyclin E meets dysfunction in p53: closing the escape hatch on breast cancer.
Academic Article	Cdk2 is required for breast cancer mediated by the low-molecular-weight isoform of cyclin E.
Academic Article	The low molecular weight (LMW) isoforms of cyclin E deregulate the cell cycle of mammary epithelial cells.
Academic Article	Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors.
Academic Article	Low molecular weight cyclin E is associated with p27-resistant, high-grade, high-stage and invasive bladder cancer.
Academic Article	Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer.
Academic Article	LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers.

Search Criteria

Cyclin E